Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > $RVV $RVVTF - cut & paste post as usual .. from Yahoo !

<< Previous

Bullboard Posts

Next >>

Comment by cool888on May 04, 2021 8:44pm

99 Views

Post# 33129502

RE:RE:$RVV $RVVTF - cut & paste post as usual .. from Yahoo !

1ottrunner wrote: FALSE 1. This is not almost as good as EUA, that's idiotic 2. The fact did NOT expand the trial I'll end there. You realize that people are remortgaging their homes, ya? On bad DD. Moron.

cool888 wrote: "starting a trial for severe covid, the update never said that, it just said the current phase 3 clincial trial ''will position Bucillamine as a potential oral treatment option for mild-moderate to severe COVID-19'' this update is even better than expected and i reckon nearly as good as EUA, the FDA just expanded the trail parameters because bucillamine is obviously working, just how good are those thiols at working against this life sucking covid 19??? All the research is pointing at this being the real deal. this + the way the chart is looking / we are retesting the breakout above .485 downward trend yday, if we hold that at + .49 we are flying it, and could get some serious gap ups very soon. When this gets even more institutional (cannacord etc) and retail hype, + EUA covid vaccine or viral approval, we will be +$10 i reckon, if OCGN can do it on less,we should be able to the same if not surpass it in similar mkt environment..... glta"